Tianjin, China

Qingchao He

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Tianjin Hemay Oncology Pharmaceutical Co., Ltd., Tianjin Hemay Bio-Tech Co., Ltd.. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingchao He. Retrieved from https://idiyas.com/inventor/qingchao-he

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Qingchao He: Innovator in Cyanoquinoline Derivatives

Introduction

Qingchao He is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyanoquinoline derivatives. With a total of three patents to his name, He has established himself as a key figure in his area of expertise.

Latest Patents

His latest patents include innovative compounds of formula I, which encompass stereoisomers, cis-trans isomers, tautomers, and mixtures thereof. These compounds are also described as pharmaceutically acceptable salts, solvates, or prodrugs. The focus on cyanoquinoline derivatives highlights his commitment to advancing pharmaceutical science.

Career Highlights

Qingchao He has worked with prominent companies such as Tianjin Hemay Oncology Pharmaceutical Co., Ltd. and Tianjin Hemay Bio-tech Co., Ltd. His experience in these organizations has allowed him to contribute to groundbreaking research and development in oncology and biotechnology.

Collaborations

He has collaborated with esteemed colleagues, including Hesheng Zhang and Yingwei Chen. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Qingchao He is a distinguished inventor whose work in cyanoquinoline derivatives has the potential to influence the pharmaceutical industry significantly. His contributions and collaborations reflect his dedication to innovation and excellence in research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…